Precision medicine – treatments that are based on an individual’s specific genetics and the cancer cell’s genes – holds great promise for lung cancer patients. For all patients, precision medicine is made possible through a type of advanced diagnostic testing called biomarker testing. However, for some racial and ethnic minorities,…more.
- RWHC Home
- About RWHC
- Alzheimer’s Disease
- Amyotrophic Lateral Sclerosis
- Behavioral Health
- Movement Disorders
- Big Data
- Multiple Myeloma
- CAR-T Cell Therapy
- Non-Small Cell Lung Cancer
- Nonalcoholic Steatohepatitis
- COVID 19
- Pain Management
- Cystic Fibrosis
- Parkinson’s Disease
- Health Disparities
- Personalized Medicine
- Hepatitis C
- Secondary Progressive MS
- Macular Degeneration
Last March, as the COVID-19 pandemic started its relentless progression across the United States, hospitals and clinics nationwide closed their doors to all but the most gravely ill patients. While certain elective procedures and well visits were paused temporarily, patients with cancer didn’t have the luxury of waiting for things…more.
November is Lung Cancer Awareness Month, a time when the medical community, patients and their loved ones, advocacy organizations and industry come together to raise awareness and support for the number one cancer killer of men and women in the United States. Lung Cancer Trends For example, this year, the…more.
This week, Real World Health Care continues our series on caregiving by speaking with Deborah P. Brown, Chief Mission Officer of the American Lung Association. Brown oversees strategic planning and implementation of the Association’s health promotions programs, advocacy efforts and research programs. We talked about lung cancer programs and services…more.
This April marks the LUNGevity Foundation‘s second COPE Summit, held during its 9th Annual International Lung Cancer Survivorship Conference, April 26-28 in Washington, D.C. Directed toward caregivers of loved ones with lung cancer, the COPE Summit is one of three simultaneous summits at the Conference, which features a full weekend…more.
Real World Health Care concludes its series on non-small cell lung cancer by speaking with Erica Carpenter, MBA, PhD, Research Assistant Professor in the Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania. Dr. Carpenter also serves as Director of the Circulating Tumor Material Laboratory…more.
Continuing our series on non-small cell lung cancer, this week Real World Health Care speaks with Lecia V. Sequist, MD, MPH, Associate Professor of Medicine at Harvard Medical School and the Mary B. Soltonstall endowed chair in oncology at Massachusetts General Hospital. Dr. Sequist’s research focuses on studying novel targets…more.
As part of our series on non-small cell lung cancer (NSCLC), Real World Health Care spoke with Hossein Borghaei, D.O., in the Department of Hematology/Oncology at Fox Chase Cancer Center, which is part of the Temple Health System. Dr. Borghaei serves as Chief, Thoracic Medical Oncology; Director, Lung Cancer Risk…more.
This week, Real World Health Care speaks with lung cancer specialist, Gregory Masters, MD, FASCO, attending physician at the Helen F. Graham Cancer Center and associate professor at the Thomas Jefferson University Medical School. In addition to being Fellow of the American Society for Clinical Oncology, Dr. Masters is co-chair…more.
As part of our series on non-small cell lung cancer (NSCLC), Real World Health Care spoke with Susan J. Rappaport, MPH, vice president for research and scientific affairs, American Lung Association. Rappaport provides leadership and direction in the development and implementation of the American Lung Association public health education and…more.